Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
+9.07M
-
Total reported value, excl. options
-
$293M
-
Value change
-
+$73.4M
-
Put/Call ratio
-
0.94
-
Number of buys
-
54
-
Number of sells
-
-20
-
Price
-
$8.08
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q2 2020
102 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q2 2020.
AVADEL PHARMACEUTICALS - COM (AVDL) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.31M shares), Avoro Capital Advisors LLC (4.57M shares), Vivo Capital, LLC (3.53M shares), RA CAPITAL MANAGEMENT, L.P. (3.13M shares), Polar Capital LLP (2.98M shares), COWEN AND COMPANY, LLC (1.91M shares), ACUTA CAPITAL PARTNERS, LLC (1.75M shares), BRANDES INVESTMENT PARTNERS, LP (1.48M shares), RENAISSANCE TECHNOLOGIES LLC (1.34M shares), and VR Adviser, LLC (1.06M shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.